Chiang Mai Ram Medical Business PCL (BKK:CMR)
Thailand · Delayed Price · Currency is THB 1.300
0.00 (0.00%)
Sep 3, 2026, 11:57 AM ICT
BKK:CMR Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,496 | 2,496 | 2,547 | 5,066 | 5,205 | 4,193 |
Other Revenue | 29.75 | 41.13 | 34.04 | 78.72 | 64.48 | 51.08 |
| 2,526 | 2,537 | 2,581 | 5,144 | 5,269 | 4,244 | |
Revenue Growth | 108.15% | -1.71% | -49.83% | -2.37% | 24.17% | 14.17% |
Cost of Revenue | 2,066 | 2,063 | 2,077 | 3,914 | 3,792 | 3,255 |
Gross Profit | 459.36 | 473.94 | 504.46 | 1,230 | 1,477 | 988.66 |
Selling, General & Admin | 344.15 | 340.97 | 422.52 | 712.34 | 657.84 | 528.56 |
Operating Expenses | 344.15 | 340.97 | 422.52 | 712.34 | 657.84 | 528.56 |
Operating Income | 115.21 | 132.97 | 81.94 | 518.13 | 819.27 | 460.1 |
Interest Expense | -89.54 | -99.3 | -108.6 | -148.17 | -119.12 | -86.04 |
Interest & Investment Income | - | - | - | 99.9 | 82.04 | 68.28 |
Earnings From Equity Investments | 34.18 | 7.91 | -7.01 | 15.13 | 18.04 | 11.95 |
EBT Excluding Unusual Items | 59.84 | 41.59 | -33.67 | 485 | 800.23 | 454.29 |
Gain (Loss) on Sale of Investments | - | - | - | - | 35.25 | - |
Gain (Loss) on Sale of Assets | 2,422 | 2,422 | - | - | - | -0.22 |
Pretax Income | 2,591 | 2,573 | -33.67 | 485 | 835.47 | 454.07 |
Income Tax Expense | 77.21 | 76.66 | 18.18 | 102.14 | 151.31 | 77.89 |
Earnings From Continuing Operations | 2,514 | 2,497 | -51.84 | 382.86 | 684.16 | 376.18 |
Earnings From Discontinued Operations | -106.41 | -56.48 | 172.51 | - | - | - |
Net Income to Company | 2,408 | 2,440 | 120.66 | 382.86 | 684.16 | 376.18 |
Minority Interest in Earnings | 5.1 | 5.92 | 9.84 | -165.1 | -180.31 | -84.09 |
Net Income | 2,413 | 2,446 | 130.51 | 217.75 | 503.86 | 292.09 |
Net Income to Common | 2,413 | 2,446 | 130.51 | 217.75 | 503.86 | 292.09 |
Net Income Growth | 2732.78% | 1774.21% | -40.07% | -56.78% | 72.50% | 47.44% |
Shares Outstanding (Basic) | 4,071 | 4,071 | 4,071 | 4,046 | 4,023 | 4,023 |
Shares Outstanding (Diluted) | 4,071 | 4,071 | 4,071 | 4,046 | 4,023 | 4,023 |
Shares Change | - | - | 0.62% | 0.57% | - | - |
EPS (Basic) | 0.59 | 0.60 | 0.03 | 0.05 | 0.13 | 0.07 |
EPS (Diluted) | 0.59 | 0.60 | 0.03 | 0.05 | 0.13 | 0.07 |
EPS Growth | 2732.88% | 1774.26% | -40.44% | -57.03% | 72.50% | 47.44% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -31.36 | 53.48 | 626.08 | 642.64 | 749.9 | -235.51 |
Free Cash Flow Per Share | -0.01 | 0.01 | 0.15 | 0.16 | 0.19 | -0.06 |
Dividend Per Share | 0.104 | 0.218 | 0.050 | 0.055 | 0.066 | 0.065 |
Dividend Growth | -36.40% | 336.60% | -9.09% | -16.67% | 1.54% | 25.00% |
Gross Margin | 18.19% | 18.68% | 19.54% | 23.92% | 28.03% | 23.30% |
Operating Margin | 4.56% | 5.24% | 3.17% | 10.07% | 15.55% | 10.84% |
Profit Margin | 95.53% | 96.41% | 5.06% | 4.23% | 9.56% | 6.88% |
Free Cash Flow Margin | -1.24% | 2.11% | 24.25% | 12.49% | 14.23% | -5.55% |
EBITDA | 466.93 | 573.17 | 552.62 | 1,008 | 1,283 | 802.2 |
EBITDA Margin | 18.49% | 22.59% | 21.41% | 19.59% | 24.34% | 18.90% |
D&A For EBITDA | 351.73 | 440.2 | 470.68 | 489.71 | 463.48 | 342.11 |
EBIT | 115.21 | 132.97 | 81.94 | 518.13 | 819.27 | 460.1 |
EBIT Margin | 4.56% | 5.24% | 3.17% | 10.07% | 15.55% | 10.84% |
Effective Tax Rate | 2.98% | 2.98% | - | 21.06% | 18.11% | 17.15% |
Revenue as Reported | 5,057 | 5,069 | 2,581 | 5,244 | 5,387 | 4,312 |